Compare HTHT & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTHT | TOVX |
|---|---|---|
| Founded | 2005 | 2001 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 7.3M |
| IPO Year | 2010 | 2006 |
| Metric | HTHT | TOVX |
|---|---|---|
| Price | $49.05 | $0.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $47.00 | N/A |
| AVG Volume (30 Days) | 1.4M | ★ 2.8M |
| Earning Date | 11-17-2025 | 11-12-2025 |
| Dividend Yield | ★ 3.95% | N/A |
| EPS Growth | ★ 7.24 | N/A |
| EPS | ★ 1.76 | N/A |
| Revenue | ★ $3,484,239,807.00 | N/A |
| Revenue This Year | $7.07 | N/A |
| Revenue Next Year | $6.65 | N/A |
| P/E Ratio | $27.96 | ★ N/A |
| Revenue Growth | ★ 5.77 | N/A |
| 52 Week Low | $30.13 | $0.17 |
| 52 Week High | $49.49 | $2.08 |
| Indicator | HTHT | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 70.37 | 38.79 |
| Support Level | $47.01 | $0.17 |
| Resistance Level | $48.80 | $0.24 |
| Average True Range (ATR) | 1.17 | 0.02 |
| MACD | -0.13 | -0.00 |
| Stochastic Oscillator | 88.07 | 24.56 |
H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, managed, and franchised models. The company has two operating segments: legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.